IMAX CORP (IMAX) Stock Fundamental Analysis
USA - NYSE:IMAX - CA45245E1097 - Common Stock
32.422 USD
+0.86 (+2.73%)
We assign a fundamental rating of 5 out of 10 to IMAX. IMAX was compared to 79 industry peers in the Entertainment industry. IMAX has only an average score on both its financial health and profitability. IMAX is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year IMAX was profitable.
IMAX had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: IMAX reported negative net income in multiple years.
IMAX had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
With a decent Return On Assets value of 3.77%, IMAX is doing good in the industry, outperforming 74.68% of the companies in the same industry.
The Return On Equity of IMAX (10.23%) is better than 74.68% of its industry peers.
With a decent Return On Invested Capital value of 6.88%, IMAX is doing good in the industry, outperforming 78.48% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for IMAX is below the industry average of 9.15%.
The 3 year average ROIC (4.23%) for IMAX is below the current ROIC(6.88%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.77% | ||
| ROE | 10.23% | ||
| ROIC | 6.88% |
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 9.04%, IMAX belongs to the top of the industry, outperforming 82.28% of the companies in the same industry.
In the last couple of years the Profit Margin of IMAX has declined.
IMAX has a better Operating Margin (18.00%) than 91.14% of its industry peers.
In the last couple of years the Operating Margin of IMAX has declined.
IMAX's Gross Margin of 56.88% is fine compared to the rest of the industry. IMAX outperforms 67.09% of its industry peers.
IMAX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18% | ||
| PM (TTM) | 9.04% | ||
| GM | 56.88% |
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
2. Health
2.1 Basic Checks
IMAX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, IMAX has less shares outstanding
Compared to 5 years ago, IMAX has less shares outstanding
Compared to 1 year ago, IMAX has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.32 indicates that IMAX is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.32, IMAX is doing good in the industry, outperforming 68.35% of the companies in the same industry.
IMAX has a debt to FCF ratio of 4.75. This is a neutral value as IMAX would need 4.75 years to pay back of all of its debts.
The Debt to FCF ratio of IMAX (4.75) is better than 64.56% of its industry peers.
A Debt/Equity ratio of 0.87 indicates that IMAX is somewhat dependend on debt financing.
IMAX has a Debt to Equity ratio of 0.87. This is in the lower half of the industry: IMAX underperforms 63.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.87 | ||
| Debt/FCF | 4.75 | ||
| Altman-Z | 2.32 |
ROIC/WACC0.95
WACC7.23%
2.3 Liquidity
IMAX has a Current Ratio of 2.33. This indicates that IMAX is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.33, IMAX is in the better half of the industry, outperforming 75.95% of the companies in the same industry.
IMAX has a Quick Ratio of 2.02. This indicates that IMAX is financially healthy and has no problem in meeting its short term obligations.
IMAX has a Quick ratio of 2.02. This is in the better half of the industry: IMAX outperforms 72.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.33 | ||
| Quick Ratio | 2.02 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 18.82% over the past year.
IMAX shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.17% yearly.
IMAX shows a small growth in Revenue. In the last year, the Revenue has grown by 1.25%.
Measured over the past years, IMAX shows a decrease in Revenue. The Revenue has been decreasing by -2.30% on average per year.
EPS 1Y (TTM)18.82%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%44.44%
Revenue 1Y (TTM)1.25%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%3.06%
3.2 Future
The Earnings Per Share is expected to grow by 24.18% on average over the next years. This is a very strong growth
IMAX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.79% yearly.
EPS Next Y32.98%
EPS Next 2Y26.22%
EPS Next 3Y18.66%
EPS Next 5Y24.18%
Revenue Next Year11.5%
Revenue Next 2Y8.73%
Revenue Next 3Y6.79%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
IMAX is valuated quite expensively with a Price/Earnings ratio of 32.10.
Based on the Price/Earnings ratio, IMAX is valued a bit cheaper than the industry average as 73.42% of the companies are valued more expensively.
IMAX's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.29.
With a Price/Forward Earnings ratio of 21.42, IMAX is valued on the expensive side.
Based on the Price/Forward Earnings ratio, IMAX is valued cheaper than 81.01% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of IMAX to the average of the S&P500 Index (22.85), we can say IMAX is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.1 | ||
| Fwd PE | 21.42 |
4.2 Price Multiples
IMAX's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. IMAX is cheaper than 65.82% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, IMAX is valued a bit cheaper than 74.68% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.77 | ||
| EV/EBITDA | 14.92 |
4.3 Compensation for Growth
IMAX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of IMAX may justify a higher PE ratio.
A more expensive valuation may be justified as IMAX's earnings are expected to grow with 18.66% in the coming years.
PEG (NY)0.97
PEG (5Y)N/A
EPS Next 2Y26.22%
EPS Next 3Y18.66%
5. Dividend
5.1 Amount
No dividends for IMAX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NYSE:IMAX (10/17/2025, 1:58:17 PM)
32.422
+0.86 (+2.73%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)
Earnings (Next)
Inst Owners90.65%
Inst Owner Change-0.28%
Ins Owners19.38%
Ins Owner Change-0.54%
Market Cap1.74B
Analysts80
Price Target35.33 (8.97%)
Short Float %14.04%
Short Ratio5.6
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.07%
Min EPS beat(2)11.91%
Max EPS beat(2)20.24%
EPS beat(4)3
Avg EPS beat(4)19.46%
Min EPS beat(4)-6.42%
Max EPS beat(4)52.13%
EPS beat(8)7
Avg EPS beat(8)69.57%
EPS beat(12)9
Avg EPS beat(12)28.75%
EPS beat(16)11
Avg EPS beat(16)16.57%
Revenue beat(2)1
Avg Revenue beat(2)-0.21%
Min Revenue beat(2)-1.46%
Max Revenue beat(2)1.04%
Revenue beat(4)1
Avg Revenue beat(4)-4.03%
Min Revenue beat(4)-11.37%
Max Revenue beat(4)1.04%
Revenue beat(8)3
Avg Revenue beat(8)-0.35%
Revenue beat(12)6
Avg Revenue beat(12)1.29%
Revenue beat(16)7
Avg Revenue beat(16)2.04%
PT rev (1m)3.25%
PT rev (3m)10.12%
EPS NQ rev (1m)2.21%
EPS NQ rev (3m)-0.4%
EPS NY rev (1m)0%
EPS NY rev (3m)8.34%
Revenue NQ rev (1m)0.71%
Revenue NQ rev (3m)-2.29%
Revenue NY rev (1m)0.17%
Revenue NY rev (3m)0.1%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 32.1 | ||
| Fwd PE | 21.42 | ||
| P/S | 4.81 | ||
| P/FCF | 29.77 | ||
| P/OCF | 22.66 | ||
| P/B | 5.44 | ||
| P/tB | 7.82 | ||
| EV/EBITDA | 14.92 |
EPS(TTM)1.01
EY3.12%
EPS(NY)1.51
Fwd EY4.67%
FCF(TTM)1.09
FCFY3.36%
OCF(TTM)1.43
OCFY4.41%
SpS6.74
BVpS5.96
TBVpS4.15
PEG (NY)0.97
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.77% | ||
| ROE | 10.23% | ||
| ROCE | 8.68% | ||
| ROIC | 6.88% | ||
| ROICexc | 8.05% | ||
| ROICexgc | 11.79% | ||
| OM | 18% | ||
| PM (TTM) | 9.04% | ||
| GM | 56.88% | ||
| FCFM | 16.16% |
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
ROICexc(3y)4.84%
ROICexc(5y)N/A
ROICexgc(3y)7.01%
ROICexgc(5y)N/A
ROCE(3y)5.33%
ROCE(5y)N/A
ROICexcg growth 3Y113.18%
ROICexcg growth 5Y-5.75%
ROICexc growth 3Y103.14%
ROICexc growth 5Y-8.28%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
F-Score7
Asset Turnover0.42
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.87 | ||
| Debt/FCF | 4.75 | ||
| Debt/EBITDA | 2.22 | ||
| Cap/Depr | 30.7% | ||
| Cap/Sales | 5.07% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 61.51% | ||
| Profit Quality | 178.66% | ||
| Current Ratio | 2.33 | ||
| Quick Ratio | 2.02 | ||
| Altman-Z | 2.32 |
F-Score7
WACC7.23%
ROIC/WACC0.95
Cap/Depr(3y)25.16%
Cap/Depr(5y)18.94%
Cap/Sales(3y)4.33%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.82%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%44.44%
EPS Next Y32.98%
EPS Next 2Y26.22%
EPS Next 3Y18.66%
EPS Next 5Y24.18%
Revenue 1Y (TTM)1.25%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%3.06%
Revenue Next Year11.5%
Revenue Next 2Y8.73%
Revenue Next 3Y6.79%
Revenue Next 5YN/A
EBIT growth 1Y52.22%
EBIT growth 3Y108.21%
EBIT growth 5Y-9.36%
EBIT Next Year238.45%
EBIT Next 3Y52.46%
EBIT Next 5Y33.94%
FCF growth 1Y63.61%
FCF growth 3YN/A
FCF growth 5Y-7.57%
OCF growth 1Y58.66%
OCF growth 3Y126.45%
OCF growth 5Y-4.76%